Expecting 18-20% growth for FY11: Ipca Labs

AK Jain, executive director at Ipca Laboratories, says for FY10 the company had posted 22 per cent and for this fiscal it expects growth of 18-20 per cent. The company has seen strong growth in CVS, anti-diabetic, pain management therapies.

Related Videos